Perspective Therapeutics, Inc. (CATX)
NYSE: CATX · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 1995
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 |
| Report filed | Mar 16, 2026 | Mar 26, 2025 | Mar 28, 2024 | · | May 1, 2023 | Sep 28, 2022 | Sep 27, 2021 | Sep 25, 2020 | Sep 27, 2019 | Sep 26, 2018 |
| Revenue | · | · | 1,434 | · | 0 | 10,795 | 10,053 | 9,680 | 7,314 | 5,923 |
| Cost of revenue | · | · | · | · | · | 6,179 | 4,932 | 4,556 | 4,267 | 4,081 |
| Gross profit | · | · | 1,434 | · | 0 | 0r | 5,121 | 5,124 | 3,047 | 1,842 |
| Research and development | 84,215 | 41,638 | 21,311 | · | 881 | 850r | 1,427 | 1,126 | 1,474 | 1,746 |
| Sales and marketing | · | · | · | · | · | 2,804 | 2,440 | 2,976 | 2,679 | 2,660 |
| General and administrative | 30,233 | 26,613 | 21,064 | · | 7,486 | 5,569r | 4,691 | 4,571 | 4,172 | 4,165 |
| Total operating expenses | 114,448 | 92,340 | 42,375 | · | 8,672 | 6,419r | 8,567 | 8,600 | 8,301 | 8,571 |
| Operating income | -113,564 | -90,886 | -40,941 | · | -8,672 | -6,419r | -3,446 | -3,476 | -5,254 | -6,729 |
| Interest expense | · | · | 84 | · | 0 | 0 | · | · | · | · |
| Interest and investment income | 8,114 | 10,515 | 934 | · | 618 | 119 | 59 | 30 | 108 | 29 |
| Share of profit of equity-method investments | -2 | -8 | -17 | 17 | 0 | 0 | · | · | · | · |
| Other income (expense), net | · | · | · | · | · | · | · | · | 2 | · |
| Total non-operating income (expense) | 9,136 | 10,459 | 835 | · | 618 | 119 | 59 | 30 | 110 | 29 |
| Income before income taxes | -104,428 | -80,427 | -40,106 | · | -8,054 | -6,300 | · | · | · | · |
| Income tax expense | -793 | -2,097 | -2,651 | · | 0 | 0 | 0 | 0 | 0 | 0 |
| Income from discontinued operations | · | 200 | · | · | · | · | · | · | · | · |
| Net income | -103,121 | -79,279 | -46,508 | · | -10,760 | -7,272 | -3,387 | -3,446 | -5,144 | -6,700 |
| Preferred dividends | · | · | · | · | · | 0 | 3 | 11 | 11 | 11 |
| Net income to common shareholders | · | · | · | · | · | -7,272 | -3,390 | -3,457 | -5,155 | -6,711 |
| Earnings per share, basic | -1.40 | -1.23 | -1.74r | · | -0.80b | -0.50b | -0.30b | -0.50b | · | · |
| Earnings per share, diluted | -1.40 | -1.23 | -1.74 | · | · | · | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | · | · | -0.30b | -0.50b | -0.80b | -1.20b |
| Weighted average shares, basic | 73,813.0 | 64,425.0 | 26,764.0r | · | 14,206.7b | 14,198.7b | 10,384.1b | 6,760.1b | · | · |
| Weighted average shares, diluted | 73,813.0 | 64,425.0 | 26,764.0 | · | · | · | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | · | 10,384.1b | 6,760.1b | 6,704.2b | 5,515.9b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split of Jun 2024.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from discontinued operations profit or loss from businesses it sold or closed
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntityNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossPreferred dividends paid to preferred holders before common shareholders
us-gaap:PreferredStockDividendsIncomeStatementImpactNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted